CIPO Releases IG Transition Report

We are pleased to share the final report on the latest IG transition. As this transition greatly affects the primary immunodeficiency community, CIPO hopes that the results of this report will assist in decision making in future transitions.

 

If you have any questions or concerns regarding this report, please contact CIPO Executive Director, Whitney Goulstone: whitney.goulstone@cipo.ca